Association of human serum apolipoprotein A5 with lipid profiles affected by gender

Clinica Chimica Acta

Volumn 376, Issue 1-2, 2007, Pages 68-71

  Zhao, Shui Ping ^a   Hu, Song ^a   Li, Jiang ^a   Hu, Ming ^a   Liu, Qing ^a   Wu, Li Jun ^b   Zhang, Tao ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Promab Biotechnologies Inc   (United States)

Author keywords

ApoA5; Gender; Lipid profile

Indexed keywords

APOLIPOPROTEIN A5; LIPID; MONOCLONAL ANTIBODY; PLASMA PROTEIN;

ADULT; ARTICLE; BODY MASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; APOLIPOPROTEINS A; BODY MASS INDEX; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS, HDL; MALE; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 33845290267     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.07.014     Document Type: Article

References (18)

1. Hokanson J.E., and Austin M.A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol concentration: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3 (1996) 213-219
2. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 86 (2000) 943-949
3. Malloy M.J., and Kane J.P. A risk factor for atherosclerosis: triglyceride-rich lipoproteins. Adv Intern Med 47 (2001) 111-136
4. Hopkins P.N., Wu L.L., Hunt S.C., and Brinton E.A. Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease. J Am Coll Cardiol 45 (2005) 1003-1012
5. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in human and mice revealed by comparative sequencing. Science 294 (2001) 169-173
6. Van der Vliet H.N., Sammelsm M.G., Leegwater A.C., et al. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 276 (2001) 44512-44520
7. Van der Vliet H.N., Schaap F.G., Levels J.H., et al. Adenoviral overexpression of apolipoprotein A-V reduces serum level of triglycerides and cholesterol in mice. Biochem Biophys Res Commun 295 (2002) 1156-1159
8. Schaap F.G., Rensen P.C., Voshol P.J., et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 279 (2004) 27941-27947
9. Fruchart-Najib J., Baugé E., Niculescu L.S., et al. Mechanism of lipid lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 319 (2004) 397-404
10. Merkel M., Loeffler B., Kluger M., et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280 (2005) 21553-21560
11. Prieur X., Coste H., and Rodriguez J.C. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element. J Biol Chem 278 (2003) 25468-25480
12. Vu-Dac N., Gervois P., Jakel H., et al. Apolipoprotein A5, a crucial determinant of plasma triglyceride level, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J Biol Chem 278 (2003) 17982-17985
13. Genoux A., Dehondt H., Helleboid-Chapman A., et al. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor ROR-α. Arterioscler Thromb Vasc Biol 25 (2005) 1186-1192
14. Jakel H., Nowak M., Moitrot E., et al. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c. J Biol Chem 279 (2004) 45462-45469
15. O'Brien P.J., Alborn W.E., Sloan J.H., et al. The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins. Clin Chem 51 (2005) 351-359
16. Ishihara M., Kujiraoka T., Iwasaki T., et al. A sandwich enzyme-linked immunosorbent assay for human plasma apolipoprotein A-V concentration. J Lipid Res 46 (2005) 2015-2022
17. Grosskopf I., Baroukh N., Lee S.J., et al. Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants. Arterioscler Thromb Vasc Biol 25 (2005) 2573-2579
18. Nowak M., Helleboid-Chapman A., Jakel H., et al. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor. Mol Cell Biol 25 (2005) 1537-1548